Add to ORKGThe association between venous thromboembolism and cancer has been recognized for over 140 years. This article reviews current prevention, diagnosis and treatment of cancer-related venous thromboembolism, and highlights emerging anticoagulants and the possible anticancer effects of anticoagulants such as low molecular weight heparins
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in cancer patients and lea...
The evidence of the important two-way clinical correlation between cancer and venous thromboembolism...
This article is a review of epidemiology, pathogenesis and treatment of venous thromboembolism (VTE)...
The association between venous thromboembolism and cancer has been recognized for over 140 years. Th...
Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated w...
Cancer represents a well recognized risk factor for venous thromboembolism. Patients with cancer hav...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Emerging d...
The association between cancer and venous thromboembolism (VTE) has been established for more than 1...
Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased...
The relationship between venous thromboembolism and cancer has been known for many years, and there ...
Ozlem Er1, Leo Zacharski21Department of Medical Oncology, Erciyes University Medical Faculty, Kayser...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased...
Abstract: Cancer is a major risk factor for the development of venous thromboembolism (VTE). Convent...
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in cancer patients and lea...
The evidence of the important two-way clinical correlation between cancer and venous thromboembolism...
This article is a review of epidemiology, pathogenesis and treatment of venous thromboembolism (VTE)...
The association between venous thromboembolism and cancer has been recognized for over 140 years. Th...
Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated w...
Cancer represents a well recognized risk factor for venous thromboembolism. Patients with cancer hav...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Emerging d...
The association between cancer and venous thromboembolism (VTE) has been established for more than 1...
Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased...
The relationship between venous thromboembolism and cancer has been known for many years, and there ...
Ozlem Er1, Leo Zacharski21Department of Medical Oncology, Erciyes University Medical Faculty, Kayser...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased...
Abstract: Cancer is a major risk factor for the development of venous thromboembolism (VTE). Convent...
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in cancer patients and lea...
The evidence of the important two-way clinical correlation between cancer and venous thromboembolism...
This article is a review of epidemiology, pathogenesis and treatment of venous thromboembolism (VTE)...